392 related articles for article (PubMed ID: 19700654)
21. Which colorectal cancer screening test is best?
Mandel JS
J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
[No Abstract] [Full Text] [Related]
22. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.
Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I
Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563
[TBL] [Abstract][Full Text] [Related]
23. [Screening for colorectal cancer by determination of occult blood in the feces].
Restellini A; De Peyer R; Loizeau E
Rev Med Suisse Romande; 1991 Jun; 111(6):483-8. PubMed ID: 1862270
[No Abstract] [Full Text] [Related]
24. Recent advances in the molecular diagnosis and prognosis of colorectal cancer.
Huerta S
Expert Rev Mol Diagn; 2008 May; 8(3):277-88. PubMed ID: 18598107
[TBL] [Abstract][Full Text] [Related]
25. [Future perspectives in screening for colorectal cancer].
Kronborg O
Ugeskr Laeger; 2005 Oct; 167(44):4193-4. PubMed ID: 16266579
[TBL] [Abstract][Full Text] [Related]
26. Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
Capellá G
Nat Clin Pract Oncol; 2005 May; 2(5):234-5. PubMed ID: 16264954
[No Abstract] [Full Text] [Related]
27. Colorectal screening in Germany.
Pox C; Schmiegel W
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S31-2. PubMed ID: 18368638
[No Abstract] [Full Text] [Related]
28. Performance of multitarget stool DNA testing in African American patients.
Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L
Cancer; 2018 Oct; 124(19):3876-3880. PubMed ID: 30193399
[TBL] [Abstract][Full Text] [Related]
29. Screening for colorectal cancer.
Launoy G
N Engl J Med; 2001 Dec; 345(25):1850-1; author reply 1851-2. PubMed ID: 11803913
[No Abstract] [Full Text] [Related]
30. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2009 Feb; 29(4):450-7. PubMed ID: 19035980
[TBL] [Abstract][Full Text] [Related]
31. Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.
Calistri D; Rengucci C; Casadei Gardini A; Frassineti GL; Scarpi E; Zoli W; Falcini F; Silvestrini R; Amadori D
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2647-54. PubMed ID: 20929882
[TBL] [Abstract][Full Text] [Related]
32. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
[TBL] [Abstract][Full Text] [Related]
33. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
[TBL] [Abstract][Full Text] [Related]
34. Stool test for colorectal cancer screening: what is going on?
Bonanno E; Rulli F; GalatĂ G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
[TBL] [Abstract][Full Text] [Related]
35. [Usefulness of combining a immunological fecal occult blood test (latex method) with a chemical test (guaiac method)].
Hamajima E; Asai T; Okumura S; Yamaguchi H; Katou T; Yamamoto Y; Kinoshita O
Gan No Rinsho; 1990 Jan; 36(1):71-4. PubMed ID: 2299793
[TBL] [Abstract][Full Text] [Related]
36. Early diagnosis and prevention of sporadic colorectal cancer.
Lambert R; Provenzale D; Ectors N; Vainio H; Dixon MF; Atkin W; Werner M; Franceschi S; Watanabe H; Tytgat GN; Axon AT; Neuhaus H
Endoscopy; 2001 Dec; 33(12):1042-64. PubMed ID: 11740647
[No Abstract] [Full Text] [Related]
37. Next-generation stool DNA testing: expanding the scope.
Ahlquist DA
Gastroenterology; 2009 Jun; 136(7):2068-73. PubMed ID: 19379748
[No Abstract] [Full Text] [Related]
38. Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer.
Fraser CG; Mathew CM; McKay K; Carey FA; Steele RJ
Gut; 2008 Sep; 57(9):1256-60. PubMed ID: 18467371
[TBL] [Abstract][Full Text] [Related]
39. Colorectal Adenomas.
Strum WB
N Engl J Med; 2016 Mar; 374(11):1065-75. PubMed ID: 26981936
[No Abstract] [Full Text] [Related]
40. [Colorectal cancer screening. Where are we?].
Benhaberou-Brun D
Perspect Infirm; 2013; 10(3):52-5. PubMed ID: 23710531
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]